The facility is expected to produce 500 million vaccine doses annually
Kenya has signed a deal with US biotechnology company, Moderna Inc, to build a vaccine manufacturing facility in the country.
The facility if expected to produce up to 500 million doses of vaccines annually.
The deal has been hailed as one that will help solve vaccine access in the current coronavirus pandemic and in future pandemics.
Moderna anticipates to invest more than $500m (£380m) in the facility.
DISCLAIMER: The Views, Comments, Opinions, Contributions and Statements made by Readers and Contributors on this platform do not necessarily represent the views or policy of Multimedia Group Limited.
Latest Stories
-
Miss Health Ghana 2024: Kujori Esther Cachana crowned new Health Ambassador
7 mins -
Livestream: The manifesto debate on WASH and climate change
13 mins -
Alan Kyerematen saddened by NDC and NPP’s neglect of Krofrom Market in the Ashanti Region
17 mins -
CSIR Executive Director urges farmers to adopt technology for improved farming
30 mins -
Football Impact Africa’s Ghetto Love Initiative inspires change in Teshie
42 mins -
Peter Toobu calls for tighter border security over uncovered weapons at Tema Port
44 mins -
Gov’t has failed its commitment to IPPs – Ablakwa
48 mins -
Sell Chrome to end search monopoly, Google told
60 mins -
KATH to install seven new dialysis machines by end of November
1 hour -
Walewale: Police confiscate 37 bags of cocoa beans suspected of being smuggled out of Ghana
1 hour -
‘Expired’ Rice Scandal: FDA confirms rice was safe for consumption after rigorous lab tests
1 hour -
Many women have experienced intimate partner violence – Angela Dwamena Aboagye
2 hours -
Power challenges persist due to government’s mismanagement of revenues – Okudzeto Ablakwa
2 hours -
Jordan Ayew injury not as bad as feared – Leicester City boss
2 hours -
Stonebwoy heads to North America for UP & RUNNIN6 tour
3 hours